Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isee3D Inc ISEDF

GREY:ISEDF - Post Discussion

Isee3D Inc > IT'S A DEAL ... NEWS WITH $$$
View:
Post by red2000 on Jun 30, 2010 4:55pm

IT'S A DEAL ... NEWS WITH $$$

WOW !

1ST REVENUES EVER ! It's a start !

RED2000

ISee3D Enters Agreement to Commercialize 3D in Advanced Laser Imaging Systems

Wednesday, June 30, 2010

TORONTO, ONTARIO--(Marketwire - June 30, 2010) - ISee3D Inc. (TSX VENTURE:ICT) announced today that it has entered into a license agreement with Hamilton Thorne Ltd., a leading provider of advanced laser systems and instruments for in-vitro cell applications.

Hamilton Thorne will combine commercial microscopes with their advanced laser imaging systems, utilizing ISee3D's patented single-lens single camera 3D technology, for stem cell regenerative medicine and fertility clinic markets worldwide. ISee3D and Hamilton Thorne are collaborating on prototype development with one of the world's leading lens and microscope designers and manufacturers, with the objective of having a commercial product ready for sale in 2011.

"This agreement with Hamilton Thorne lays out a clear commercialization path for microscopes empowered with our single-lens single camera 3D technology," said ISee3D CEO Dwight Romanica. "We look forward to working with Hamilton Thorne, and our design and manufacturing partner, on development of both a prototype and a leading commercially ready single-lens single camera 3D microscope."

"Our research customers have long sought a simple and cost effective method to incorporate true 3D images into their laser applications," says Meg Spencer, Hamilton Thorne CEO. "I believe that the extraordinary quality of the image in the ISee3D technology will represent a major advantage to researchers in the IVF and stem cell fields."

Under the terms of the agreement, ISee3D has granted Hamilton Thorne exclusive worldwide rights, for a three-year period, to commercialize a product, incorporating ISee3D's single-lens 3D technology in their laser imaging systems used in stem cell regenerative medicine and fertility clinic markets worldwide. Hamilton Thorne has agreed to pay ISee3D a one-time license fee of $150,000.00 USD, in addition to a royalty on each unit sold. Under the agreement, ISee3D is also guaranteed a minimum annual royalty.

Comment by red2000 on Jun 30, 2010 7:49pm
About Hamilton Thorne...Hamilton Thorne partners with Leica MicrosystemsThursday, May 27, 2010Leading microscope and optical systems producer to distribute Hamilton Thorne's laser products in North AmericaTSX VENTURE: HTLTORONTO, May 27 /CNW/ - Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets ...more  
Comment by stockarchangel on Jul 01, 2010 10:26am
The only complaint I have is that the NR came out less than an hour before close of trading, and the day before a holiday.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities